samedan logo
 
 
spacer
home > ict > Winter 2013
PUBLICATIONS

International Clinical Trials

ict
Winter 2013

   
Text
PDF
Editor’s Comment

Despite the burden and complexity of adverse event reporting, Graham Hughes considers whether the industry is doing enough in this area.
 
view
download pdf
bullet
REGULATORY

Pharmacovigilance

A Safer Europe

Despite the benefits of modern medicines, there is mounting evidence of the dangers too, in the form of adverse reactions. Mieke Notenbaert at Emtex outlines the rigorous drug safety measures that have evolved, including the latest European legislation.

 
view
download pdf
bullet
TRIAL MANAGEMENT
Adaptive Designs

Dose of Reality

Vladimir Dragalin at Aptiv Solutions explores how the use of adaptive designs in dose-ranging studies can improve our ability to effi ciently learn about the dose response and better determine whether to take a drug forward.

 
view
download pdf
Trial Management Systems

Death of CTMS?

The potential demise of clinical trial management systems has been greatly exaggerated. They may have earned a bad reputation in the past but, says Simon Wilson at ArisGlobal, a new generation of these systems has much to offer clinical operations teams.
 
view
download pdf
Site Equipment

Kitted Out?

Equipment supply to investigator sites is ever-more critical. Pierre Malingrey of Quipment offers some tips on the logistical and information issues – from tracking items to contract options – that should be considered early in the study design process.
 
view
download pdf
bullet
Clinical Trial Outsourcing

Outsourcing Models

Starting Point

Under pressure to do more with less, many small- to mid-sized pharma companies are asking whether it is better to set up a pharmacovigilance department in-house or outsource it. Donelle Bussom from ICON Clinical Research compares the options.

 
view
download pdf
bullet
eCLINICAL

e-Patient Update

Digital Connectors

With e-Patients demanding and sharing more and more health-related information online, Pete Chan at Tudor Reilly Health assesses the industry implications and sees an opportunity to drive public awareness and recruitment of trials.

 
view
download pdf

Operational Software

Reach for the Sky

Early concerns about the open nature of cloud-based software initially slowed its adoption by pharma but, as Jen Goldsmith at Veeva Systems explains, the benefits in terms of document workflows and broader efficiencies are now an exciting prospect.

 
view
download pdf

Investigator Site Files

Electronic Edge

As the industry continues to go electronic, paper-based investigator site files are inevitably giving way to eISFs. Phlexglobal’s Gillian Gittens argues that the process and compliance improvements are significant, but so too are the obstacles to implementation.

 
view
download pdf
bullet
Clinical Trial Supply & Packaging

Product Labelling

Multiple Choice

Frank Jäger and Nurdan Citamak at Faubel examine how labels once used as secondary packaging for investigational products are now multifunctional tools that convey variable data in different languages and help ensure safe and userfriendly products.

 
view
download pdf

Clinical Supply Data

Mind Your Language

Prompted by industry-wide inconsistencies in managing local language data, PRISYM ID’s Vince Postill calls for a more integrated and country-specific approach to label and booklet design.

 
view
download pdf
bullet
PREVIEW
PCT Congress Q&A

Customer First

Trudie Lobban, a keynote speaker at the upcoming Partnerships in Clinical Trials Congress, considers how better patient involvement would help overcome fears about the industry.
 
view
download pdf
bullet
Regional trials

Eastern Europe

Ukraine Calling

Ukraine is currently in the ‘sweet spot’ between emerging on the scene and being saturated with trials. Pavle Vukojevic and Oleksandr Iaroshkevych of Pharm-Olam International take a look at this former Soviet republic now edging towards the European Union.

 
view
download pdf

Regional Focus

CEE for Yourself

With studies in Central and Eastern Europe more than tripling over the past five years, the need to fully understand the region’s varying dynamics is critical. Marcin Ernst and Cristina Stefanescu at INC Research give the lowdown.

 
view
download pdf
African Infrastructure

Continental Shift

The growing attention on Africa as an investment destination, and increasing talk about the continent as an economic force, unveils tremendous opportunities for R&D pioneers. Marieme Ba, Suemyya Warrak and Beatrice Coly at Pharmalys report.
 
view
download pdf
bullet
DRUG DISCOVERY & DELIVERY
Rare Diseases

Changing Lives

With more rare diseases being discovered each year, a dramatic rise in orphan drug development is taking place. Rani Abraham and Rabinder Buttar of ClinTec International predict the trial potential of the Middle East and North Africa as the industry plays catch up.
 
view
download pdf
bullet
data management & statistical analysis
Risk-Based Monitoring

Under Surveillance

The increasing importance of central statistical surveillance is indicative of the crucial role of statistics and programming in effective clinical trial monitoring. Chitra Lele and Samyuktha Ajay at Sciformix evaluate this risk-based approach.
 
view
download pdf
Data Collection

People Power

Timely, well-planned communication and education goes a long way in helping investigator site staff overcome the growing technology burden stemming from electronic data capture. Caroline Chin and Chuck Johnston from AXON Communications report.
 
view
download pdf
Information Management

Content is King

Managing the core information and regulatory data assets of a company has become a complex and risky business, raising the need for more sophisticated content-centric solutions, advises Satish Tadikonda at Virtify, Inc.
 
view
download pdf

Interview
Business Insight

Look Local

The intricacies of running successful trials in Central and South Eastern Europe are outlined by Takis Zervakakis of Zeincro.
 
view
download pdf
Industry Interview

Thinking Allowed

Myoderm’s Michael Cohen talks to ICT about the surge in demand for comparator drugs, and the big sourcing and supply issues ahead.
 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Merck Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection

• Provides rapid production of antibody drug conjugates (ADCs) for best candidate selection • Established platform technology to reliably scale target molecules • Reduces time to clinic through comprehensive ADC services from pre-clinical to commercial from a single source
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>

Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement